Nuvalent
Jimmy Yung is a seasoned finance professional with extensive experience in financial planning and analysis (FP&A) across various industries, including biotechnology and private equity. Currently serving as the Senior Manager of FP&A at Nuvalent, Inc. since April 2023, Jimmy previously held similar senior management positions at Vir Biotechnology, Inc. and Pliant Therapeutics, where responsibilities included managing significant annual budgets, leading strategic financial planning, and facilitating corporate accounting processes. With a proven track record in developing financial strategy decks and investor presentations, as well as experience in capital raises and IPO readiness, Jimmy has also contributed to acquisitions in prior roles at Sangamo Therapeutics and has amassed diverse experience in various financial capacities since starting a career at Wells Fargo. Educational qualifications include a Bachelor of Arts in Economics and Psychology from the University of California, Davis, and a Certificate in Financial Planning and Services from UC Berkeley Extension.
This person is not in any teams
This person is not in any offices
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.